Joaquin Duato

Worldwide Chairman,

Joaquin Duato is Worldwide Chairman, Pharmaceuticals, Johnson & Johnson, a position he assumed in January 2011. A member of the Johnson & Johnson Management Committee, Joaquin is responsible for the global commercial businesses of the Janssen Pharmaceutical Companies of Johnson & Johnson. In this role, he also oversees the Operations, Quality, and Compliance functional groups that support the pharmaceutical Commercial and Research & Development organizations.

Prior to his current role, Joaquin held the position of Company Group Chairman, The Americas. His team was responsible for key pharmaceutical product launches and strong growth of major therapeutic franchises in Canada, the United States and Latin America. Previously, he was Company Group Chairman, Ortho Clinical Diagnostics, Inc., once a Johnson & Johnson company in the Medical Devices & Diagnostics segment.

Joaquin’s professional experience in the healthcare industry spans sales, marketing and general management. He began his career at Johnson & Johnson in 1989 with Janssen-Cilag Spain and later became Managing Director of Janssen-Cilag Italy. He then led Ortho Biotech Europe before relocating to the United States in 2002 to serve as President, Ortho Biotech Products, L.P. in 2005.

A native of Valencia, Spain, Joaquin holds an undergraduate degree in economics and two master’s degrees — one in business administration from ESADE Business School in Barcelona; the other in international management from Thunderbird in Phoenix, Arizona.

Joaquin is a member of the Board of Directors of the Pharmaceutical Research & Manufacturers of America (PhRMA). He currently serves as its elected Treasurer and chair of the State Committee. He is also a member of the Board of the European Federation of the Pharmaceutical Industry and Associations (EFPIA), the Board of Trustees of Save the Children, and the International Advisory Board of the ESADE Business School.

Joaquin resides in Bridgewater, New Jersey, with his wife and two children.


Joaquin News & Multimedia

Joaquin Duato Jennifer Garner Moms Social Good

2030 and Beyond

Joaquin Duato, Worldwide Chairman, Pharmaceuticals, writes about the start of the Global Moms Relay that Johnson & Johnson is launching in partnership with the United Nations Foundation. Every day until Father’s Day, a celebrity, community leader or everyday mom and dad will share a personal story about what kind of future they envision for their family and the world in 2030.

Helping Others

Helping Others

Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson, recently spoke about his passion and commitment to diversity and inclusion. Read his remarks in our corporate blog.

Fortune's Most Admired

Fortune ranks J&J as top pharmaceutical company on its Most Admired List

For the second consecutive year FORTUNE Magazine ranked Johnson & Johnson and its Janssen Pharmaceutical Companies #1 in the Pharmaceuticals category on its annual World’s Most Admired Companies list. J&J senior leaders Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, and Joaquin Duato, Worldwide Chairman, Janssen Pharmaceutical Companies, co-authored a blog about this honor and our commitment to healthcare innovation.

PwC’s 18th Annual Global CEO Survey

PwC's 18th Annual Global CEO Survey

Joaquin Duato, Worldwide Chairman of our Janssen Pharmaceutical Companies, was asked to participate in the 18th Annual PricewaterhouseCoopers (PwC) LLC Global CEO Survey on behalf of Johnson & Johnson and our senior leadership team. Joaquin shares some of his business perspectives in this interview.

Joaquin Duato talks to CNBC about fast-tracking an Ebola vaccine

CNBC's Meg Tirrell speaks to Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson about the Company's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.

Joaquin Duato Interview with Bloomberg

Joaquin Duato Interview with Bloomberg

In an interview on Bloomberg TV, Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson, discussed our pharmaceutical products launched since 2009, coupled with the new products expected to emerge from our pipeline, are planned to account for nearly half of the total sales in the segment by 2017.

Acting on Behalf of the Children

Acting on Behalf of the Children

Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson guest authored a blog on Huffington Post’s Global Motherhood blog about his September 2014 trip to Texas to learn about the Save the Children humanitarian work being done to help children.

For the Children's Future

For the Children's Future

Johnson & Johnson’s Joaquin Duato and Sarah Colamarino write about the importance of investing in a child’s future from birth through the important developmental years and beyond. Learn how the long-standing partnership between Save the Children and J&J continues to help support children around the globe.